Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.440
+0.080 (5.88%)
At close: Aug 11, 2026, 4:00 PM EDT
1.450
+0.010 (0.69%)
After-hours: Aug 11, 2026, 4:50 PM EDT
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $21.57 million as of August 11, 2026. Its market cap has increased by 26.89% in one year.
Market Cap
21.57M
Enterprise Value
10.23M
1-Year Change
26.89%
Ranking
Category
Stock Price
$1.44
ChartMarket Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $21.57M, a decrease of -77.99%. That is a compound annual growth rate of -11.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 21.57M | -21.85% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 22.12M |
| Quantum BioPharma | 22.08M |
| Polyrizon | 21.69M |
| NextCure | 21.09M |
| Neuphoria Therapeutics | 20.65M |
| Cellectar Biosciences | 20.54M |
| Cocrystal Pharma | 20.42M |
| Atossa Therapeutics | 20.32M |